Back Home Search

Non-Production - Relapsed / Refractory

    • Protocols

    • UW18115

      OPEN TO ACCRUAL

      Phase I/II Study of Nivolumab + Ruxolitinib in Relapsed/Refractory Classical Hodgkins Lymphoma